New York–based hematologist-oncologist and clinical researcher works to lower the barriers to enrolling in clinical trials.

Members of the Leukemia and Lymphoma Society discussed the importance of educating others, fundraising and spreading ...

More than 13 years after its initial FDA approval, Pfizer’s blood cancer drug Adcetris has nabbed another regulatory green ...

This study presents an optimized CRISPR-Cas12a system for large-scale genetic screening, revealing critical genes involved in ...

"It's a little overwhelming, but everyone's been so amazing and supportive and it makes me feel really great," junior Taylor LaRoche said, who was diagnosed with Hodgkin's Lymphoma last Christmas Eve ...

Doctors are enrolling patients in a groundbreaking clinical trial aimed at reducing cancer recurrence in patients with ...

Assemblywoman Selena La Rue Hatch announced she submitted a bill draft request aimed at expanding the availability of paid ...

The waveLINE-010 trial will compare zilovertamab vedotin, in combination with rituximab plus cyclophosphamide, doxorubicin, ...

With positive mid-stage results in marginal zone lymphoma, Bristol Myers Squibb could soon add a new indication for the CAR T ...

The righthander can finally see the end of a long journey that started with a diagnosis of Stage 4 non-Hodgkin’s lymphoma in ...

The Food and Drug Administration expanded its approval of one of Pfizer's drugs, Adcetris, allowing it to be used as a treatment for certain types of lymphoma.

The businesswoman spoke exclusively with PEOPLE about learning how to be more comfortable with bringing more private elements ...